Saltar al contenido
Merck
  • ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

The American journal of gastroenterology (2013-04-10)
Evan S Dellon, Nirmala Gonsalves, Ikuo Hirano, Glenn T Furuta, Chris A Liacouras, David A Katzka
RESUMEN

Esophageal eosinophilia and eosinophilic esophagitis (EoE) are increasingly recognized and prevalent conditions, which now represent common clinical problems encountered by gastroenterologists, pathologists, and allergists. The study of EoE has become a dynamic field with an evolving understanding of the pathogenesis, diagnosis, and treatment. Although there are limited data supporting management decisions, clinical parameters are needed to guide the care of patients with eosinophilic-esophageal disorders. In this evidence-based review, recommendations developed by adult and pediatric gastroenterologists are provided for the evaluation and management of these patients. New terminology is emphasized, particularly the concepts of esophageal eosinophilia and proton-pump inhibitor-responsive esophageal eosinophilia (PPI-REE) as entities distinct from EoE.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Fluticasone propionate, ≥98% (HPLC), powder
Fluticasone propionate, European Pharmacopoeia (EP) Reference Standard